Exposure Keratopathy in Mechanically Ventilated Patients: Clinical Insights, Mechanisms, and Management

Abstract

Exposure keratopathy is a frequent but often underdiagnosed ocular complication among mechanically ventilated patients, particularly in critical care settings. This article reviews the epidemiology, pathophysiological mechanisms, risk factors, clinical manifestations, diagnostic approach, management strategies, and recent advances in the prevention and treatment of exposure keratopathy in this vulnerable population. Drawing upon recent evidence and current guidelines, the review highlights the importance of multidisciplinary collaboration to reduce the burden of ocular morbidity in intensive care units (ICUs), ensuring optimal visual and overall outcomes for critically ill patients.

Introduction

Mechanical ventilation is a cornerstone of modern critical care, supporting patients with respiratory failure due to diverse etiologies. However, prolonged sedation and neuromuscular blockade, in conjunction with environmental factors and systemic illness, place mechanically ventilated patients at significant risk for ocular surface complications, notably exposure keratopathy. This condition, characterized by inadequate eyelid closure and subsequent corneal drying and injury, can lead to infectious keratitis, corneal ulceration, scarring, and permanent visual impairment if unrecognized or undertreated. Despite its high prevalence in ICUs, exposure keratopathy remains underappreciated, with variability in preventive and therapeutic practices. This comprehensive review synthesizes current knowledge and evidence-based recommendations to guide clinicians in the identification, prevention, and management of exposure keratopathy in mechanically ventilated patients.

Epidemiology / Disease Burden

Exposure keratopathy occurs in approximately 20% to 60% of mechanically ventilated patients, with incidence rates varying according to sedation protocols, duration of mechanical ventilation, and the implementation of eye care bundles. ICU-acquired ocular surface disease is associated with increased length of stay, higher risk of secondary infections, and adverse visual outcomes. The true burden is likely underestimated due to inconsistent screening and documentation. Recent multicenter studies emphasize the importance of standardized ocular assessments, revealing that up to one-third of ICU patients develop some degree of corneal exposure during their admission.

Pathophysiology

The pathogenesis of exposure keratopathy in mechanically ventilated patients is multifactorial. Sedative medications and neuromuscular blocking agents lead to decreased blink reflex and incomplete eyelid closure (lagophthalmos), resulting in increased corneal exposure. Reduced tear production, common in critically ill individuals, compromises the ocular surface\'s protective tear film. Positive pressure ventilation, especially with high levels of PEEP, may exacerbate venous congestion and eyelid edema, further impeding eyelid apposition. The cumulative effect is desiccation and breakdown of the corneal epithelium, rendering it susceptible to microbial invasion and secondary infection. The risk is compounded by systemic factors such as sepsis, hypotension, and altered immune responses.

Risk Factors

Major risk factors for exposure keratopathy in the mechanically ventilated population include prolonged sedation, neuromuscular blockade, high severity of illness, facial or orbital trauma, pre-existing ocular surface disease, and diminished baseline tear production. Additional risk is conferred by prone positioning, oxygen delivery devices causing airflow across the ocular surface, and inadequate eye care practices. Patients with diabetes mellitus, thyroid eye disease, or prior ocular surgery are also at increased risk. Awareness of these risk factors is crucial for targeted screening and preventive strategies.

Clinical Features

The clinical spectrum of exposure keratopathy ranges from mild punctate epithelial erosions to severe corneal ulceration and perforation. Early signs include ocular surface dryness, conjunctival injection, and punctate keratopathy visible on fluorescein staining. Progression may result in epithelial defects, stromal thinning, secondary bacterial or fungal infections, and ultimately, corneal opacification or perforation. In non-communicative, sedated patients, clinical suspicion must be maintained, as symptoms such as pain or photophobia may be absent. The presence of lagophthalmos and reduced or absent blink reflex on examination are important clinical clues.

Diagnosis

Diagnosis of exposure keratopathy is primarily clinical, relying on regular, systematic ocular examination in at-risk patients. Eyelid position assessment and the use of fluorescein dye to detect corneal epithelial defects are essential. Slit-lamp examination, if feasible, offers greater sensitivity for early and subtle changes. In the ICU, portable tools such as penlights and bedside fluorescein strips provide practical alternatives. Documentation of findings and communication with ophthalmology for advanced or refractory cases are recommended. Microbiological sampling should be considered if infection is suspected.

Treatment & Management

Prevention is the cornerstone of management. Regular ocular lubrication with preservative-free artificial tears or ointments, eyelid taping, and moisture chamber devices are first-line interventions. For patients with persistent lagophthalmos or evolving keratopathy, temporary tarsorrhaphy may be warranted. Avoidance of irritants, humidification of the environment, and minimization of direct airflow across the face further reduce risk. In cases with secondary infection, prompt initiation of appropriate topical antibiotics or antifungals is required. Multidisciplinary protocols incorporating nursing and medical staff training have demonstrated efficacy in reducing incidence and severity of exposure keratopathy in ICU settings.

Recent Advances / Emerging Therapies

Recent advances include the development of novel moisture chamber goggles, self-adhesive eyelid closure devices, and slow-release ocular lubricants tailored for critically ill patients. Emerging therapies under investigation involve biologic tear substitutes, such as autologous serum eye drops, and anti-inflammatory agents to promote corneal healing. Machine learning algorithms for automated risk prediction and integration of ocular assessment into electronic health records are being explored to facilitate early detection and intervention. Teleophthalmology consultations have expanded access to specialist input in resource-limited settings, improving outcomes through rapid evaluation and tailored management.

Guideline Recommendations

Current guidelines from critical care and ophthalmology societies recommend routine ocular assessments in all mechanically ventilated patients, with standardized protocols for eye care. Preventive measures should be initiated at the outset of mechanical ventilation, and escalation to ophthalmology referral is indicated for persistent or progressive corneal pathology. Staff education, adherence monitoring, and regular audit of eye care practices are emphasized to ensure guideline compliance and optimize patient safety. The implementation of bundled care approaches has been shown to significantly reduce the incidence of exposure keratopathy and its complications.

Conclusion

Exposure keratopathy represents a significant yet preventable cause of ocular morbidity in mechanically ventilated patients. A thorough understanding of its risk factors, pathophysiology, and clinical manifestations is essential for timely diagnosis and effective intervention. Evidence-based preventive strategies, multidisciplinary collaboration, and adherence to guideline recommendations are key to minimizing the impact of this complication. Ongoing research and technological advancements hold promise for further improving the quality of ocular care in critical care environments, ultimately preserving vision and enhancing patient outcomes.